Behavioural Brain Research 2008-04-01

Oxiracetam prevented the scopolamine but not the diazepam induced memory deficits in mice.

Jainendra Kumar Jain, M S Prakash, Rajnish K Mishra, Amit P Khandhar

Index: Behav. Brain Res. 133(2) , 395-9, (2002)

Full Text: HTML

Abstract

In mice, the elevated plus-maze paradigm was used to investigate the effect of scopolamine hydrobromide and diazepam and their interaction with oxiracetam on the retrieval of spatial memory trace. This paradigm measures (using the transfer latency) an animal's capacity to escape from the open arm to the enclosed one. The retention session followed 24 h after the acquisition one. Experiment 1: Scopolamine (0.25 and 0.5 mg/kg) and diazepam (0.5 and 1.0 mg/kg) given 30 min before the retention session significantly prolonged the transfer latency as compared with the saline treated mice and those given the lowest dose of scopolamine (0.125 mg/kg) and diazepam (0.25 mg/kg). Experiment 2: Oxiracetam administered at doses of 3, 10 and 30 mg/kg immediately after the acquisition session prevented the scopolamine induced prolongation of the transfer latency. Thus, oxiracetam forestalled the impairment of retrieval of memory trace: the animals were able to remember the spatial configuration of the plus-maze. On the contrary, oxiracetam was not effective in the diazepam treated mice. We suggest that beneficial effect of oxiracetam might be confounded or blocked by the anxiolytic effect of diazepam.


Related Compounds

  • Oxiracetam

Related Articles:

Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice.

1995-01-01

[Pol. J. Pharmacol. 47(1) , 69-73, (1995)]

Pre- and postprandial pyridostigmine and oxiracetam effects on growth hormone secretion in anorexia nervosa.

1996-10-01

[Psychoneuroendocrinology 21(7) , 621-9, (1996)]

Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors.

1995-01-16

[Eur. J. Pharmacol. 272(2-3) , 203-9, (1995)]

Relationships between arousal and cognition-enhancing effects of oxiracetam.

1994-02-01

[Pharmacol. Biochem. Behav. 47(2) , 283-7, (1994)]

Enhancement of contextual fear-conditioning by putative (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice.

1997-09-12

[Brain Res. 768(1-2) , 197-207, (1997)]

More Articles...